Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
ERJ Open Research|October 13, 2016
Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical modelsRoland Hubaux, Fabian Vandermeers, Jean-Philippe Cosse, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2009
Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammationBi-Sen Ding, Nankang Hong, Melpo Christofidou-Solomidou, et al.
American Journal of Nuclear Medicine and Molecular Imaging|June 13, 2015
In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probeShaojuan Zhang, Pin Shao, Xiaoxi Ling, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 13, 2019
Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosisToru Kimura, James Monslow, Astero Klampatsa, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2009
Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatmentBogdan D Grigoriu, Bachar Chahine, Anil Vachani, et al.
American Journal of Respiratory Cell and Molecular Biology|April 17, 2010
Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cellsZvi G Fridlender, Veena Kapoor, George Buchlis, et al.
The Journal of Clinical Investigation|September 11, 2013
Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumorsKwan-Hyuck Baek, Dongha Bhang, Alexander Zaslavsky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2006
Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancerMichael J Wilderman, Samuel Kim, Collin T Gillespie, et al.
Pageof 23